Serum CA 125 combined with transvaginal ultrasonography for ovarian cancer screening

Zoi Roupa, Efthimios Faros, Vasilios Raftopoulos, Georgios Tzavelas, Evangelia Kotrotsiou, Penelope Sotiropoulou, Evridiki Karanikola, Evdoxia Skifta, Alexandros Ardavanis

Research output: Contribution to journalReview articlepeer-review

7 Citations (Scopus)


Background: The aim of this study was to evaluate the combination of serum CA125 and Transvaginal Ultra Sonography (TVUS) score, as a screening procedure for ovarian cancer in premenopausal and postmenopausal women. Patients and Methods: A retrospective case-control pilot study was conducted. The files of 120 women with ovarian neoplasia detected by TVUS and increased CA125 level, within the framework of a prevention program, were reviewed. The relationship between the above tests and epithelial malignancy was investigated using the SPSS-12 program for Windows. Results: The combination of CA125 value exceeding 30U/ml and a TVUS score ≥35 had a sensitivity of 81.7% and specificity of 100% in predicting ovarian cancer. Mathematical analysis of the logistic model of our variables revealed a mathematical model that can calculate the likelihood of ovarian cancer detection, by using a combination of CA125≥30U/ml and TVUS score≥35. Conclusion: By combining TVUS and CA125, an accurate prediction for the presence of ovarian cancer may be achieved. Further investigation in a larger population is warranted.

Original languageEnglish
Pages (from-to)831-836
Number of pages6
JournalIn Vivo
Issue number6
Publication statusPublished - Nov 2004


  • CA 125
  • Menopausal status
  • Ovarian cancer screening
  • Transvaginal ultrasonography


Dive into the research topics of 'Serum CA 125 combined with transvaginal ultrasonography for ovarian cancer screening'. Together they form a unique fingerprint.

Cite this